Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis

被引:5
作者
Zhang, Bo
Katafuchi, Ritsuko
Arishima, Hiroaki
Matsunaga, Akira
Rye, Kerry-Anne
Saku, Keijiro
机构
[1] Fukuoka Univ, Sch Med, Dept Cardiol, FACP,FACC,Jonan Ku, Fukuoka 8140180, Japan
[2] Hara Sanshin Hosp, Dept Cardiol, Fukuoka, Japan
[3] Heart Res Inst, Sydney, NSW, Australia
[4] Univ Sydney, Dept Internal Med, Sydney, NSW 2006, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia
关键词
capillary isotachophoresis (cITP); charge-based lipoprotein subtractions; apolipoprotein A-I/phosphatidylcholine (POPC) discs; triglyceride-rich lipoprotein (TRL); atorvastatin;
D O I
10.1016/j.cca.2006.04.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The present study examined the effects of atorvastatin and the in vitro effect of apolipoprotein (apo) A-I/phosphatidylcholine (POPC) discs on charge-based triglyceride-rich lipoprotein (TRL) subfractions in a patient with type III hyperlipoproteinemia (HLP) and the apoE2/2 phenotype. Methods: Charge-based lipoprotein subfractions were characterized by capillary isotachophoresis (cITP). cITP analysis was performed using plasma that had been prestained with a lipophilic dye on a Beckman P/ACE MDQ system. Results: Treatment with atorvastatin for 4 weeks markedly decreased the slow (s)-migrating TRL subfraction and both fast- and slow-migrating low-density lipoprotein (LDL) subtractions, but did not affect the fast (f)-migrating TRL subfraction in this patient. ApoA-I/POPC discs consisted of two major charge-based subfractions that had the mobility of cITP fTRL and sTRL. Incubation of plasma from this patient in the presence of apoA-I/POPC discs caused not only a reduction in cITP fast- and intermediate-migrating HDL and an increase in cITP sHDL but also a reduction in fTRL and sTRL and an increase in sLDL. Conclusion: Atorvastatin and apoA-I/POPC discs decreased cITP TRL subfractions in a complementary manner, suggesting that the combination of apoA-I/POPC discs and atorvastatin could be a promising therapeutic approach for hypertriglyceridemia. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 37 条
[1]   Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia [J].
Bilz, S ;
Wagner, S ;
Schmitz, M ;
Bedynek, A ;
Keller, U ;
Demant, T .
JOURNAL OF LIPID RESEARCH, 2004, 45 (01) :174-185
[2]  
Böttcher A, 2000, J LIPID RES, V41, P905
[3]   Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs [J].
Burnett, JR ;
Wilcox, LJ ;
Telford, DE ;
Kleinstiver, SJ ;
Barrett, PHR ;
Newton, RS ;
Huff, MW .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2589-2600
[4]   Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity [J].
Chan, DC ;
Watts, GF ;
Barrett, PHR ;
Mori, TA ;
Beilin, LJ ;
Redgrave, TG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2283-2289
[5]   Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice [J].
Chroni, A ;
Kan, HY ;
Kypreos, KE ;
Gorshkova, IN ;
Shkodrani, A ;
Zannis, VI .
BIOCHEMISTRY, 2004, 43 (32) :10442-10457
[6]   Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins [J].
Cohn, JS ;
Marcoux, C ;
Davignon, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2474-2486
[7]   Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia [J].
Cohn, JS ;
Tremblay, M ;
Batal, R ;
Jacques, H ;
Veilleux, L ;
Rodriguez, C ;
Barrett, RHR ;
Dubreuil, D ;
Roy, M ;
Bernier, L ;
Mamer, O ;
Davignon, J .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1464-1471
[8]  
DAVIGNON J, 1996, ATHEROSCLEROSIS SUPP, V124, P57
[9]   ULTRACENTRIFUGAL EVIDENCE OF A SPECIAL SUBTYPE OF MIXED HYPERLIPIDEMIA [J].
DEGENNES, JL ;
DAIROU, F ;
HAMON, P ;
TRUFFERT, J .
ATHEROSCLEROSIS, 1977, 27 (04) :493-497
[10]   Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates [J].
Forster, LF ;
Stewart, G ;
Bedford, D ;
Stewart, JP ;
Rogers, E ;
Shepherd, J ;
Packard, CJ ;
Caslake, MJ .
ATHEROSCLEROSIS, 2002, 164 (01) :129-145